Deepinder Goyal’s Temple wearable draws scrutiny over health claims
In short
Deepinder Goyal’s Temple wearable, priced at ₹85,000, has come under scrutiny. Doctors questioned its claims about brain blood flow and its unvalidated Entropy metric.
Goyal says Temple is a fitness and wellness product, not a medical device. That matters because the debate is about how the wearable should be seen and what health claims it can make.
What the reporting says
Deepinder Goyal’s ₹85,000 Temple wearable drew scrutiny from doctors over claims about brain blood flow and its unvalidated Entropy metric. The reaction centers on whether the wearable’s claims are medically supported, with concern focused on the product’s health-related positioning.
Why it matters
The same summary says Goyal calls it a fitness and wellness product rather than a medical device. The issue matters for consumers evaluating the product and for the company’s positioning around health-related features and claims.